Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure

Overview of attention for article published in The Journal of Headache and Pain, November 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 1,417)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 45 news outlets

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 10 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 151 followers.

This paper unpicks the messiness of measuring recurrent migraine after taking an acute treatment. Is a treatment effective if the migraine recurs within 24 hours? 48 hours? If a second dose or another medication works within 24-48 hours? It’s complicated!

29 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.